Armstrong & McMillan (1957) identified 4-hydroxy-3-methoxymandelic acid (vanilmandelic acid) in normal human urine and demonstrated that increased quantities were excreted after noradrenaline infusion and by patients with the catecholamine-secreting tumour, phaeochromocytoma. Subsequent work has established that 3-methoxylation followed by oxidative deamination to 4-hydroxy-3-methoxymandelic acid is a major metabolic pathway of both noradrenaline and adrenaline (see Axelrod, 1959) . Some 4-hydroxy-3-methoxymandelic acid is also formned by an alternative pathway in which oxidative deamination precedes 3-methoxylation (Kopin, 1960).
Armstrong & McMillan (1957) identified 4-hydroxy-3-methoxymandelic acid (vanilmandelic acid) in normal human urine and demonstrated that increased quantities were excreted after noradrenaline infusion and by patients with the catecholamine-secreting tumour, phaeochromocytoma. Subsequent work has established that 3-methoxylation followed by oxidative deamination to 4-hydroxy-3-methoxymandelic acid is a major metabolic pathway of both noradrenaline and adrenaline (see Axelrod, 1959) . Some 4-hydroxy-3-methoxymandelic acid is also formned by an alternative pathway in which oxidative deamination precedes 3-methoxylation (Kopin, 1960) .
About 45 % of the total noradrenaline and adrenaline production in man is excreted as 4-hydroxy-3-methoxymandelic acid (Kopin, 1960) compared with a free-amine excretion of only 1-4 % (Euler & Luft, 1951;  Goldenberg, Serlin, Edwards & Rapport, 1954) . Estimation of small concentrations of free catecholamines in urine demands specialized skills and equipment for the biological or fluorimetric procedures involved; results are often conflicting and depend on the method of assay (Goldenberg et al. 1954) . Catechol compounds generally are inherently unstable. It is thus likely that 4-hydroxy-3-methoxymandelic acid, by virtue of its stability and relatively large output, will provide a better guide to noradrenaline and adrenaline turnover, if a simple technique for its assay were available. A number of quantitative techniques have been described (Armstrong, Shaw & Wall, 1956; Robinson, Ratcliffe & Smith, 1959; Smith, Schweitzer & Wortis, 1959;  Weise, Mc. Donald & LaBrosse, 1960; Studnitz & Hanson 1959) but none of these methods is well suited to the clinical laboratory.
We have given preliminary reports of a colorimetric method for 4-hydroxy-3-methoxymandelic acid assay (Sandler & Ruthven, 1959a, b 5-9 (50 ml.) and the fines were aspirated after standing for 10 min. The creamy mixture was poured into a column (2-5 cm. x 50 cm.), the excess of fluid drained off, and the packed resin eluted with 4m-ammonium acetate, pH 5-9 (about 400 ml.) until the eluate was almost chloride-free. The excess of buffer was then removed by washing the column with water (about 500 ml.) and, after draining, the resin was extruded and stored damp at 4°.
Procedure. From 1-0 ml. (or 0-5 ml., see below) of urine diluted with 1 ml. of water an autoclaved sample was prepared as described by Sandler & Ruthven (1959a) except that Dowex AG1-X2 (acetate form) was used, the ethyl acetate extract was evaporated in a stream of N, instead of in vacuo, and the evaporated extract was dissolved in 0-23N-HCI instead of 5% H2SO4. A tube containing 2-5 ml. of vanillin standard and 0-2 g. of alumina was autoclaved at the same time. A 2-0 ml. portion of the autoclaved solution was adjusted with 0-4 ml. of 2m-diethanolamine to approx. pH 9-1. The precipitate of A1(OH), which formed removed any chromogens present and was separated by centrifuging. The clear colourless supernatant liquid was transferred to a 10 mm. cuvette (capacity 3-5 ml.). The partly filled cell was placed in its carrier with its base raised 5 mm. to ensure an unobstructed light-path, and the extinction read against water at 365 and 380 m,nt. Sodium borohydride solution (approx. 0-1 ml.) was then added and after 30 min. the extinction redetermined at 365 and 380 m,s in the same cell. Obstruction of the light-path by bubbles of H. from the borohydride was avoided by using cells freshly cleaned in chromic acid and by dislodging any bubbles that did form by sharply tapping the cuvette with the finger just before reading. The autoclaved vanillin standard was treated in a similar way. If the extinctions at wavelength A of autoclaved urine extracts before and after treatment with sodium borohydride are indicated by TA and TBA and the corresponding extinctions of autoolaved vanillin standards by SA and SBA, the amount of4-hydroxy-3-methoxymandelic acid in the urine specimen (1 or 0-5 ml.) is
Collection of urine 8amples. Specimens (24 hr.) were acidified with 25 ml. of acetic acid (A.R.). Although 4-hydroxy-3-methoxymandelic acid is very stable in urine, decomposition of bicarbonate during elution of an alkaline urine tends to cause disruption of the coluimn.
Comments on the mehod The eluate from two columns, one containing 10OAg. of 4-hydroxy-3-methoxymandelic acid in 1 ml. of water and the other 100,.g. in 1 ml. of urine, was collected in 1 ml.
fractions. The peak level of 4-hydroxy-3-methoxymandelic acid was found in the same fraction (9 ml.) in each column.
Extraction of 4-hydroxy-3-mehoxymandelic acid from acetate buffer. Only about 5% of 4-hydroxy-3-methoxymandelic acid was extracted from acetate buffer with equal volumes of ethyl acetate, with or without satiaration with NaCl; however, acidification (pH < 1) and saturation with NaCl caused about 75% of the 4-hydroxy-3-methoxymandelic acid to pass into the organic phase. Paper-chromatographic identification of vaniUin. Auto- claved extracts of normal urine or of urine from patients with phaeochromocytoma, prepared without alumina, were evaporated to dryness at 370 in an incubator. The residues were chromatographed on Whatman no. 1 filter paper by the ascending method in propan-2-ol-aq. NH3 soln. (sp.gr. 0.88)-water (20:1:2, by vol.). Two-dimensional chromatograms were also prepared with butan-l-olpyridine-water (10:3:3, by vol.) as second solvent. Papers were dried in a stream of warm air and dipped in a mixture of 0 003 % (w/v) indole in ethanol-orthophosphoric acid (3:5, v/v) (Sandler & Ruthven, 1959 a). Vanillin, which was invariably present in urine extracts from normal subjects and present in increased concentration in phaeochromocytoma urine extracts, appeared as a pink spot (B, 0.5 in the propan-2-ol system; 0.8 in the butan-l-ol system). p-Hydroxybenzaldehyde, usually present in trace amounts which were not increased in phaeochromocytoma, showed as an orange spot (Rp 0 6 in the propan-2-ol system; 0o85 in the butanol system). These were the only substances detected except for a purple spot, shown to be an artifact, near the origin in both solvent systems and an occasional faint-brown spot that developed late (B, 0-3 in the propan-2-ol system; 0-2 in the butanol system).
Spectrophotometric estimation of vaniUin. The absorption max. of vanillin shifts to a higher wavelength with an increase in pH (Englis & Wallerman, 1957) . Vanillin in diethanolamine buffer, pH 9 1, has an absorption max. in water at 347 mu (Fig. 1) . p-Hydroxymandelic acid, present in normal urine (Armstrong et al. 1956 ), is converted during autoclaving into p-hydroxybenzaldehyde, which has an absorption max. at 330 mje (Fig. 1) . Dihydroxymandelic acid, which occurs in urine (Goodall, 1959) would presumably be similarly converted into dihydroxybenzaldehyde in the autoclave. This compound could not be detected, however, in autoclaved extracts of urine to which the parent acid had been added.
Advantage has been taken of the rapid and approximately linear change in extinction of vanillin between 360 and 380 m, (Fig. 1) Further precision has been obtained by measuring extinction before and after the addition of sodium borohydride to the alkaline solution. Vanillin is reduced and its reduction products show negligible absorption at 365 or 380 mp (Pisano, 1960) . Under the conditions used, vanillin obeys Beer's Law up to an extinction difference (365-380 mIt) of 0-8.
When the observed curve of the autoclaved extract from a typical normal urine (curve A, Fig. 2 a) was corrected for non-reducible material (curve E) the resultant curve (B) did not coincide in shape or height with a theoretical curve (D) for vanillin at a concentration calculated to be present in the extract. Curve D was constructed from the known curve of pure vanillin at a concentration equal to that obtained by applying the formula given above to the relevant extinction measurements of the extract. This 4-Hydroxy-3-methoxymandelic acid (mg./24 hr.) 2-5, 2-7 3-0, 3-1, 3-2 3-6, 4-0, 3-9 4-9, 5-0, 4-7 4-2, 4-6, 4-5, 4-2, 4-5 2-0, 2-4, 2-1 3-7, 3-8, 3-9 4-0, 4-0 4-2, 4-0, 4-0, 4-7 2-8, 2-5 difference between the curves (curve C) was produced by reducible material other than vanillin, which has not been identified. When the vanillin content of the extract was relatively high, as in urine from patients with phaeochromocytoma (Fig. 2b) , curves B and D are nearly coincident; for, whereas the concentration of reducible non-vanillin substances was similar to that in extracts of normal urine, its percentage contribution to total extinction was much lower. As the absorption curve of non-vanihhin reducible material was practically flat between 365 and 380 m&, even in normal urine (six subjects), its effect on the assessment of true vanillin, and therefore of 4-hydroxy-3-methoxymandelic acid content, was minimized by the differential method of calculation.
Recovery of 4-hydroxy-3-methoxymandeic acid from water and urine. Replication of estimations appeared to be adequate (Table 1) and there was no great variation in the recovery of 4-hydroxy-3-methoxymandelic acid added to urine or water between concentrations of 1-25 and 100ug./ ml. (Table 2 ). The recovery of 4-hydroxy-3-methoxymandelic acid from urine (73±6-6% S.D., 28 determinations) was similar to that from water (67±5-3% S.D., 23 determinations). Recoveries of only 40-56 % of added 4-hydroxy-3-methoxymandelic acid were obtained from fresh concentrated urine specimens (8), whereas 65-75% was usually recovered from more dilute urine (5). By using 0-5 ml. of urine instead of 1-0 ml., and diluting with 1-0 ml. of water before running into the resin, the recovery of 2.5pg./ml. of added 4-hydroxy-3-methoxymandelic acid was raised from 55 to 85 % and from 56 to 83 % respectively in two different concentrated specimens. It was only neceasary to use 0-5 ml. of urine instead of I ml. when the volume of the 24 hr. specimen was less than 1200 ml.
RESULTS
The excretion of 4-hydroxy-3-methoxymandelic acid by 15 normal young adults in 24 hr. 4-HYDROXY-3-METHOXYMANDELIC ACID IN URINE lower than those reported by Sandler & Ruthven (1959a, b) . The present range is in better agreement with the values found by other workers (see Studnitz, 1960) . This is largely accounted for by the measurement of vanillin by differential spectrophotometry which was subject to less interference from other materials than the previous colorimetric estimation and gave reproducible values (Table 1) . A marked rise in 4-hydroxy-3-methoxymandelic acid output occurred in every patient with phaeochromocytoma examined. These concentrations returned to normal within 7 days after the tumour tissue had been removed (Table 3) .
There is no evidence to suggest that the constituents of a general diet interfere with the assay. Ingestion of coffee, which may give falsely high Table 4 . Recovery of 4-hydroxy-3-methoxymandelic acid (2.5 ug./ml.) from urine8
The number of specimens is given in parentheses.
Description of urine With added glucose 2 % (w/v) (2) 5% (w/v) (1) Table 2 . Recovery of 4-hydroxy-3-methoxymandelic acid added to urine or water 4-Hydroxy-3-methoxymandelic acid was added to 1.0 ml. of water, 1.0 ml. of urine (1) and 0-5 ml. of urine (2), the urines containing respectively 1-6 and 5-2 ig. of endogenous 4-hydroxy-3-methoxymandelic acid/ml. readings in a qualitative test for 4-hydroxy-3-methoxymandelic acid (Gitlow, Ornstein, Mendlowitz, Khassis & Kruk, 1960) , did not bring about any apparent increase of 4-hydroxy-3-methoxymandelic acid excretion in two successive 4-hourly urine samples (30 g. of 'Nescafe', one subject). Although bananas contain high concentrations of noradrenaline (Waalkes, Sjoerdsma, Creveling, Weissbach & Udenfriend, 1958) their ingestion (12 g./kg. body wt., five subjects) did not give rise to any increased 4-hydroxy-3-methoxymandelic acid excretion in eight successive hourly urine samples, when compared with a base-line value. This confirms the findings of Studnitz (1960) . After 15 mg. of oral noradrenaline (one subject) no rise in 4-hydroxy-3-methoxymandelic acid output was detected in eight successive hourly samples. Even when 4-hydroxy-3-methoxymandelic acid itself was given orally (one subject) only about 35 % was recovered in urine collected hourly during the next 8 hr., by which time endogenous excretion levels had been reached. This is in general agreement with the findings of Armstrong & McMillan (1959) . Oral isoprenaline sulphate (40 mg., one subject) had no effect on 4-hydroxy-3-methoxymandelic acid excretion, as noted by Gitlow, Mendlowitz, Khassis, Cohen & Sha (1960) .
The only drug whose ingestion so far has been found to interfere with the estimation is p-acetamidophenol. A subject excreted 300 ,ug. of 4-hydroxy-3-methoxymandelic acid in the 60 min. before ingestion of 2 g. ofp-acetamidophenol. After dosage the value obtained was 1 mg. in 100 min. and 1-56 mg. inthe next hour. The apparent increase in excretion was caused not by hydroxymethoxymandelic acid but by a substance with a different absorption curve from that of vanilluin. Salicylate, which increases the extinction in the colorimetric method of Sandler & Ruthven (1959a, b) Vol. 80 81 3-methoxymandelic acid from urine after salicylate ingestion was apparently unchanged (Table 4) , and its excretion appeared to remain within physiological limits (two experiments: 330 and 240 ug. in 1 hr. in control urines; 320 and 320,ug. after 100 min.; 440 and 530 ,ug. after 130 min.) . No evidence was obtained that glucose, protein, urinary metabolites of maple syrup urine disease (Dancis & Levitz, 1960) or phenylketonuria exert any effect on the recovery of 4-hydroxy-3-methoxymandelic acid from urine (Table 4) . SUMMARY 1. A method is described for measuring 4-hydroxy-3-methoxymandelic acid, a major metabolite of adrenaline and noradrenaline in human urine. The assay of this acid is a convenient index of catecholamine metabolism.
2. In the procedure, 4-hydroxy-3-methoxymandelic acid is absorbed on a column of anionexchange resin and, after elution and extraction, is converted into vanillin by autoclaving with dilute acid. The vanillin is measured spectrophotometrically.
3. The accuracy and specificity of this procedure is sufficiently high to make the method suitable for following physiological fluctuations in the low concentration of 4-hydroxy-3-methoxymandelic acid (3.9 ± 0-7 mg./24 hr.) excreted by normal subjects. Mean recoveries from urine + S.D. were 73 + 6*6 %. Some factors affecting the recovery are discussed.
4. The value of the procedure as an aid to the clinical diagnosis of the catecholamine-secreting tumour, phaeochromocytoma, is demonstrated.
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